Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarechale Cap. Regulatory News (MAC)

Share Price Information for Marechale Cap. (MAC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.50
Bid: 1.40
Ask: 1.60
Change: 0.00 (0.00%)
Spread: 0.20 (14.286%)
Open: 1.50
High: 1.50
Low: 1.50
Prev. Close: 1.50
MAC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

25 Jan 2019 10:16

RNS Number : 1397O
Marechale Capital PLC
25 January 2019
 

25 January 2019

 

Marechale Capital plc

("Marechale Capital" or the "Company")

 

Interim Results

 

Marechale Capital plc today announces its unaudited interim results for the six months ended 31 October 2018.

 

Chairman's Statement

 

I report poor operating results for the first half which are broadly in line with the same period last year: revenues of £136,000 (2017: £125,000); and an operating loss of £(251,000) (2017 £(279,000)). The Company's net loss of £(184,000) (2017: £(460,000)) is after taking into account a gain of £67,000 on the realisation of one investment and in 2017, making a provision against the fair value of options held in investee companies of £119,000 and a provision for project loss in an associate of £63,000. Whilst our current deal flow remains strong, a number of the transactions we are involved in are taking longer to complete.

 

Marechale Capital is highly selective about the management teams, as well as the companies, it advises and backs with its investor relationships. On a more positive note this long-term strategy has resulted in 2018 being the Company's best year for exits with 5 multiple investor return exits and one write-off. Successful exits include the Sheen Falls Lodge, West Country Renewables and Inn Collection and more details on these, and the other transactions, can be found on our website.

 

The Board of Marechale Capital continues to consider its options and its future strategy.

 

 

Mark Warde-Norbury

Chairman

 

 

 

For further information please contact:

 

Marechale Capital

Mark Warde-Norbury / Patrick Booth-Clibborn

 

Tel: +44 (0)20 7628 5582

Cenkos Securities

Azhic Basirov / David Jones

Tel: +44 (0)20 7397 8900

 

 

 

Consolidated Income Statement (unaudited)

 

 

6 months ended

 

 

 

 

31 October

31 October

 

 

 

 

 

2018

2017

 

 

 

 

 

£

£

Revenue

 

 

 

 

136,491

125,066

Cost of sales

 

 

 

 

(61,611)

(44,370)

 

 

 

 

 

 

 

Gross profit

 

 

 

 

74,880

80,696

 

 

 

 

 

 

 

Administrative expenses

 

 

 

(325,927)

(358,988)

 

 

 

 

 

 

 

Operating (loss)

 

 

 

(251,047)

(278,291)

 

 

 

 

 

 

 

Investment revenues

 

 

 

67,389

-

Other (losses)

Provision for project loss in associate

 

 

 

-

(118,5000)

(63,000)

 

 

 

 

 

 

 

(Loss) before tax

 

 

 

(183,658)

(459,791)

 

 

 

 

 

 

 

Taxation

 

 

 

 

-

-

 

 

 

 

 

 

 

(Loss) for the period

 

(183,658)

(459,791)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(Loss) per share

 

 

 

(Pence)

(Pence)

 

 

 

 

 

 

 

 

- Basic

 

(0.32)

(0.69)

 

- Diluted

 

 

 

(0.32)

(0.69)

 

 

 

 

 

 

 

 

 

Consolidated Balance Sheet (unaudited)

 

 

 

 

 

 

 

As at

 

 

 

 

31 October

31 October

 

 

 

 

 

 

2018

2017

 

 

 

 

 

 

£

£

 

Non current assets

 

 

 

 

 

 

Investment in associate

 

 

 

14,038

14,187

 

 

 

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

 

Available for sale investments

 

 

107,087

153,341

 

Trading investments

 

 

 

78,388

78,388

 

Trade and other receivables

 

 

80,485

69,894

 

Cash and cash equivalents

 

 

63,172

98,110

 

 

 

 

 

 

329,132

399,734

 

 

 

 

 

 

 

 

 

Total assets

 

 

 

 

343,170

413,921

 

 

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

Trade and other payables

 

 

 

(117,107)

(125,596)

 

 

 

 

 

 

 

 

 

Total current liabilities

 

 

 

(117,107)

(125,596)

 

 

 

 

 

 

 

 

 

Net assets

 

 

 

 

226,063

288,325

 

 

Equity

 

 

 

 

 

 

 

Capital and reserves attributable to equity shareholders

 

 

 

 

 

 

 

 

 

 

 

 

 

Share capital

 

 

 

 

461,449

461,449

 

Revaluation reserve

 

 

 

25,826

81,826

 

Reserve for own shares

 

 

 

(50,254)

(50,254)

 

Retained losses

 

 

 

(210,958)

(289,150)

 

Reserve for share based payments

 

 

 

-

84,453

 

 

 

 

 

 

226,063

288,325

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated Cash Flow Statement (unaudited)

 

 

 

 

 

 

6 months ended

31 October

31 October

 

 

 

 

 

2018

2017

 

 

 

 

 

£

£

Net cash from operating activities

 

 

 

 

Operating loss

 

(251,047)

(278,291)

 

 

 

 

 

 

 

Operating cash flows before movements in working capital

(251,047)

(278,291)

 

 

 

 

 

 

 

Movement in working capital

 

 

 

 

Decrease in receivables

 

 

120,689

151,781

(Decrease) in payables

 

 

(4,239)

(77,755)

 

 

 

 

 

 

 

 

 

 

 

 

116,450

74,026

 

 

 

 

 

 

Operating cash flow

 

 

 

(134,597)

(204,265)

 

 

 

 

 

 

 

Investment activities

 

 

 

 

 

Proceeds on disposal of available for sale investments

91,529

-

Expenditure on available for sale investments

Other

 

(12,700)

600

-

-

 

 

 

 

 

 

 

Cash flow from investing activities

 

 

79,429

-

 

 

 

 

 

 

 

Financing

 

 

 

 

 

 

Issue of share capital

 

 

 

-

-

Interest payable

 

 

 

-

-

 

 

 

 

 

 

 

Cash flow from financing activities

 

-

-

 

 

 

 

 

 

 

Net decrease) in cash and cash equivalents

 

(55,168)

(204,265)

 

 

 

 

 

 

 

Cash and cash equivalents at start of the period

118,340

302,375

Cash and cash equivalents at end of the period

63,172

98,110

 

 

 

 

 

 

 

(Decrease) in cash and cash equivalents

 

(55,168)

(204,265)

 

 

This financial information has been prepared in accordance with IFRS and International Financial Reporting Interpretations Committee ('IFRIC') interpretations adopted by the European Union, and with those parts of the Companies Act 2006 applicable to companies reporting under IFRS, with the prior period being reported on the same basis.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IR CKPDKKBKDDDB
Date   Source Headline
11th Aug 201410:13 amRNSHolding(s) in Company
25th Jul 201410:13 amRNSFinal Results
11th Apr 20142:33 pmRNSHolding(s) in Company
11th Apr 20148:55 amRNSDirector/PDMR Shareholding
8th Apr 20145:20 pmRNSHolding(s) in Company
18th Mar 20143:12 pmRNSHolding(s) in Company
17th Feb 20142:26 pmRNSCompletes Solar Funding Round
18th Dec 20132:37 pmRNSDirector/PDMR Shareholding
17th Dec 20137:00 amRNSInterim Results
9th Dec 20135:06 pmRNSHolding(s) in Company
17th Oct 201311:26 amRNSHolding(s) in Company
10th Oct 20132:42 pmRNSDirector/PDMR Shareholding
18th Sep 20132:12 pmRNSResult of AGM
3rd Sep 20131:45 pmRNSDirector/PDMR Shareholding
8th Aug 201311:34 amRNSPosting of Results & Notice of AGM
1st Aug 20132:13 pmRNSDirector/PDMR Shareholding
25th Jul 20134:41 pmRNSHolding(s) in Company
25th Jul 20137:00 amRNSFinal Results
26th Jun 20137:00 amRNSBoard change
3rd Apr 201310:58 amRNSDirector/PDMR Shareholding
30th Jan 20135:47 pmRNSHolding(s) in Company
13th Dec 20127:00 amRNSHalf Yearly Report
25th Sep 20123:53 pmRNSResult of AGM
17th Sep 20124:26 pmRNSPosting of Annual Report & Notice of AGM
4th Sep 20125:49 pmRNSHolding(s) in Company
4th Sep 20125:48 pmRNSHolding(s) in Company
15th Aug 20124:00 pmRNSFinal Results
18th Apr 201212:06 pmRNSDirector/PDMR Shareholding
22nd Mar 20122:53 pmRNSHolding(s) in Company
21st Feb 20123:58 pmRNSHolding(s) in Company
21st Feb 20123:54 pmRNSDirector/PDMR Shareholding
21st Dec 20117:00 amRNSHalf Yearly Report
11th Nov 20113:58 pmRNSChange of Registered Office
9th Nov 20112:50 pmRNSHolding(s) in Company
22nd Sep 201111:20 amRNSResult of AGM
20th Sep 201110:03 amRNSDirector/PDMR Shareholding
25th Aug 20119:46 amRNSFinal Results
18th Apr 20111:44 pmRNSDirector/PDMR Shareholding
14th Apr 20112:16 pmRNSHolding(s) in Company
12th Apr 20117:00 amRNSDirectorate Change
31st Mar 20113:28 pmRNSIssue of Equity
29th Mar 20113:17 pmRNSDirectorate Appointment & Dealing
28th Mar 20113:39 pmRNSDirector/PDMR Shareholding
16th Mar 20119:20 amRNSDirector/PDMR Shareholding
25th Feb 20113:46 pmRNSHolding(s) in Company
9th Feb 20112:02 pmRNSDirector/PDMR Shareholding
19th Jan 20111:34 pmRNSDirector/PDMR Shareholding
13th Jan 20114:19 pmRNSHolding(s) in Company
11th Jan 201112:27 pmRNSDirector/PDMR Shareholding
15th Dec 201012:00 pmRNSHalf Yearly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.